Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market
Holding AQST?
Track your performance easily

Aquestive Therapeutics (AQST) Financial Statements

2,003 Followers

Aquestive Therapeutics Financial Overview

Aquestive Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.354; its P/E ratio is -13.97; Aquestive Therapeutics is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 20.10M$ 12.05M$ 13.21M$ 13.00M$ 13.24M
Gross Profit$ 15.57M$ 7.66M$ 8.53M$ 8.20M$ 6.62M
EBIT$ 34.00K$ -10.31M$ -4.78M$ -919.00K$ -4.13M
EBITDA$ 2.91M$ -7.43M$ -4.31M$ -596.00K$ -3.79M
Net Income Common Stockholders$ -2.75M$ -12.83M$ -8.11M$ -3.49M$ -5.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 89.87M$ 95.20M$ 0.00$ 24.92M$ 22.44M
Total Assets$ 117.61M$ 129.52M$ 57.42M$ 59.45M$ 56.99M
Total Debt$ 23.19M$ 21.84M$ 33.32M$ 45.04M$ 45.12M
Net Debt$ -66.68M$ -73.36M$ 33.32M$ 20.12M$ 22.68M
Total Liabilities$ 153.08M$ 165.82M$ 163.91M$ 162.38M$ 163.65M
Stockholders Equity$ -35.48M$ -36.30M$ -106.49M$ -102.93M$ -106.65M
Cash Flow-
Free Cash Flow$ -7.04M$ -10.41M$ -4.96M$ -2.50M$ -8.73M
Operating Cash Flow$ -7.01M$ -10.38M$ -4.94M$ -2.35M$ -7.91M
Investing Cash Flow$ -35.00K$ -29.00K$ -16.00K$ -151.00K$ -826.00K
Financing Cash Flow$ 1.71M$ 81.74M$ 3.91M$ 4.98M$ 4.29M
Currency in USD

Aquestive Therapeutics Earnings and Revenue History

Aquestive Therapeutics Debt to Assets

Aquestive Therapeutics Cash Flow

Aquestive Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis